Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Verseon prepares for phase I study of oral anticoagulant VE-1902

June 14, 2018

MaxCyte and NIH enter CRADA for sickle cell disease

June 11, 2018

FDA approves Mircera for pediatric use

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...